TABLE 2.
Performance | 1CTR (RF) | 2PETR (RF) | 3CPR (SMO) |
(a) Adc vs. NAdc | |||
Accuracy | 81.6 | 85.0 | 100.0 |
True positive rate | 0.81 | 0.89 | 1.00 |
True negative rate | 0.82 | 0.80 | 1.00 |
Mean of precision | 0.88 | 0.85 | 1.00 |
AUC | 0.90 | 0.95 | 1.00 |
Performance | CTR | PETR | CPR |
(b) Sqc vs. NSqc | |||
Accuracy | 76.3 | 83.4 | 98.5 |
True positive rate | 0.94 | 0.90 | 0.97 |
True negative rate | 0.57 | 0.77 | 1.00 |
Mean of precision | 0.80 | 0.84 | 0.99 |
AUC | 0.89 | 0.94 | 0.99 |
(c) Primary vs. Mts | |||
Accuracy | 86.6 | 80.9 | 98.0 |
True positive rate | 0.96 | 0.92 | 0.96 |
True negative rate | 0.75 | 0.69 | 1.00 |
Mean of precision | 0.88 | 0.82 | 0.98 |
AUC | 0.98 | 0.94 | 0.98 |
*Adc, Adenocarcinoma, Sqc, squamous cell carcinoma, Mts, metastases, NAdc, not adenocarcinoma, NSqc, not squamous cell carcinoma. 1CT-based radiomics (with Random Forest classification). 2PET-based radiomics (with Random Forest classification). 3The combination of CT- and PET-based radiomics (with Sequential minimal optimization classification). The best performance metrics for each classification are highlighted in bold.